Clinical Updates in Treating Advanced Prostate Cancer - Episode 9
Panelists discuss how the CONTACT-02 trial highlights the potential of cabozantinib combined with atezolizumab in improving treatment outcomes for patients with advanced cancer.
What are your thoughts on the CONTACT-02 trial?